sur NOVACYT (EPA:ALNOV)
Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement
Novacyt, an international specialist in clinical diagnostics, has published its monthly results for August 2024 concerning the liquidity contract entrusted to Invest Securities SA. During this month, 99,268 shares were purchased at a price ranging from €0.52 to €1.35, while 131,896 shares were sold at prices ranging from €0.53 to €1.36.
As of the close of trading on August 31, 2024, the Company held 20,436 ordinary shares in treasury. The total number of ordinary shares is 70,626,248, a figure that may serve as a reference for shareholders wishing to declare or modify their interest in the Company.
Novacyt, a subscriber to the liquidity agreement since 2016, received shareholder approval in July 2024 for share purchases of up to €5.00 per share, for a maximum amount of €200,000. The agreement stipulates that Invest Securities acts independently, and it is remunerated €10,000 per year for its services. This agreement is governed by French law.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NOVACYT